Intech Biopharm Corporation announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was TWD 6.455 million compared to TWD 4.026 million a year ago. Operating loss was TWD 57.277 million compared to TWD 74.890 million a year ago. Net loss was TWD 59.672 million compared to TWD 77.120 million a year ago. Basic loss per share was TWD 0.6 compared to TWD 0.96 a year ago. For the half year, sales was TWD 11.767 million compared to TWD 8.316 million a year ago. Operating loss was TWD 114.575 million compared to TWD 142.352 million a year ago. Net loss was TWD 119.595 million compared to TWD 145.849 million a year ago. Basic loss per share was TWD 1.19 compared to TWD 1.82 a year ago.